Impact of C-reactive protein test results on evidence-based decision-making in cases of bacterial infection

BMC Pediatrics

Maria Karam¹  Abeer Hani¹  Mona Nabulsi¹ 

[1] Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, P.O. Box: 113-6044/C8, Beirut, Lebanon

关键词: Diagnostic accuracy;    Bacterial infection;    Neonatal sepsis;    C-reactive protein;   

Others  :  1170672
DOI  :  10.1186/1471-2431-12-140

 received in 2012-02-27, accepted in 2012-08-03,  发布年份 2012

【 摘 要 】

Background

C-reactive protein (CRP) is widely used to detect bacterial infection in children. We investigated the impact of CRP test results on decision-making and summarized the evidence base (EB) of CRP testing.

Methods

We collected information from the hospital records of 91 neonates with suspected sepsis and of 152 febrile children with suspected infection on the number of ordered CRP tests, the number of EB-CRP tests, and the impact of the test results on decision-making. CRP diagnostic accuracy studies focusing on pediatric infections were reviewed critically. The main outcomes were the proportion of CRP tests that were EB and the proportion of tests that affected decision-making. A secondary outcome was the overall one-year expenditure on CRP testing.

Results

The current EB for CRP testing in pediatric infections is weak and suggests that CRP is of low diagnostic value. Approximately 54.8% of tests performed for suspected neonatal sepsis and 28% of tests performed for other infections were EB; however, the results of only 12.9% of neonatal sepsis tests and of 29.9% of tests on children with other infections informed decision-making. The one-year overall cost for CRP testing and related health care was $26,715.9.

Conclusions

The routine ordering of CRP for children with infections is based on weak evidence. The impact of the CRP test results on decision-making is rather small, and CRP ordering may contribute to unnecessary health care expenditures. Better quality research is needed to definitively determine the diagnostic accuracy of CRP levels in children with infections.

【 授权许可】

   
2012 Nabulsi et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Gewurz H: Biology of C-reactive protein and the acute phase response. Hosp Pract 1982, 17:67-81.
• [2]Jaye DL, Waites KB: Clinical applications of C-reactive protein in pediatrics. Pediatr Infect Dis J 1997, 16:735-746.
• [3]Sanders S, Barnett A, Correa-Velez I, Coulthard M, Doust J: Systematic review of the diagnostic accuracy of C-reactive protein to detect bacterial infection in non-hospitalized infants and children with fever. J Pediatr 2008, 153:570-574.
• [4]Da Silva O, Ohlsson A, Kenyon C: Accuracy of leukocyte indices and C-reactive protein for diagnosis of neonatal sepsis: a critical review. Pediatr Infect Dis 1995, 14:362-366.
• [5]Den Bruel AV, Thompson MJ, Haj-Hassan T, Stevens R, Moll H, Lakhanpaul M, Mant D: Diagnostic value of laboratory tests in identifying serious infections in febrile children: systematic review. BMJ 2011, 342:d3082.
• [6]Whiting P, Rutjes A, Reitsma JB, Bossuyt P, Kleijnen J: The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003, 3:25. BioMed Central Full Text
• [7]Flood RG, Badik J, Aronoff SC: The utility of serum C-reactive protein in differentiating bacterial from non-bacterial pneumonia in children. A meta-analysis of 1230 children. Pediatr Infect Dis J 2008, 27:95-99.
• [8]van der Meer V, Neven AK, van den Broek PJ, Assendelft WJJ: Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review. BMJ 2005, 331:26.
• [9]Fowlie PW, Schmidt B: Diagnostic tests for bacterial infection from birth to 90 days – a systematic review. Arch Dis Child 1998, 78:F92-F98.
• [10]Lin Lin D-S, Huang S-H, Lin C-C, Tung Y-C, Huang T-T, Chiu N-C, Kao H-A, Hung H-Y, Hsu C-H, Hsieh W-S, Yang D-I, Huang F-Y: Urinary tract infection in febrile infants younger than eight weeks of age. Pediatrics 2000, 105:e20.
• [11]Pecile P, Miorin E, Romanello C, Falleti E, Valent F, Giacomuzzi F, Tenore A: Procalcitonin: a marker of severity of acute pyelonephritis among children. Pediatrics 2004, 114:e249-e254.
• [12]Garin EH, Olavarria F, Araya C, Broussain M, Barrera C, Young L: Diagnostic significance of clinical and laboratory findings to localize site of urinary infection. Pediatr Nephrol 2007, 22:1002-1006.
• [13]Huang DT-N, Huang F-Y, Tsai T-C, Tsai J-D, Chiu N-C, Lin C-C: Clinical differentiation of acute pyelonephritis from lower urinary tract infection in children. J Microbiol Immunol Infect 2007, 40:513-517.
• [14]Marcus N, Mor M, Amir L, Mimouni M, Waisman Y: The Quick-Read C-reactive protein test for the prediction of bacterial gastroenteritis in the pediatric emergency department. Pediatr Emerg Care 2007, 23:634-637.
• [15]Groselj-Grenc M, Repše S, Vidmar D, Derganc M: Clinical and laboratory methods in diagnosis of acute appendicitis in children. Croat Med J 2007, 48:353-361.
• [16]Principi N, Marchision P, Bigalli L, Massironi E: C-reactive protein in acute otitis media. Pediatr Infect Dis 1986, 5:525-527.
• [17]Tejani NR, Chonmaitree T, Rassin DK, Howie VM, Owen MJ, Goldman AS: Use of C-reactive protein in differentiation between acute bacterial and viral otitis media. Pediatrics 1995, 95:664-669.
• [18]Toikka P, Irjala K, Juven T, Virkki R, Mertsola J, Leinonen M, Ruuskanen O: Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J 2000, 19:598-602.
• [19]Dubos F, Moulin F, Gajdos V, De Suremain N, Biscardi S, Lebon P, Raymond J, Breart G, Gendrel D, Chalumeau M: Serum procalcitonin and other biologic markers to distinguish between bacterial and aseptic meningitis. J Pediatr 2006, 149:72-76.
• [20]Unkila-Kallio L, Kallio MJT, Eskola J, Peltola H: Serum C-reactive protein, erythrocyte sedimentation rate, and white blood cell count in acute hematogenous osteomyelitis of children. Pediatrics 1994, 93:59-62.
• [21]Unkila-Kallio L, Kallio MJT, Peltola H: The usefulness of C-reactive protein levels in the identification of concurrent septic arthritis in children who have acute hematogenous osteomyelitis. J Bone Joint Surg 1994, 76:848-853.
• [22]Roine I, Faingezicht I, Arguedas A, Herrera JF, Rodriguez F: Serial serum C-reactive protein to monitor recovery from acute hematogenous osteomyelitis in children. Pediatr Infect Dis J 1995, 14:40-44.
• [23]Kallio MJT, Unkila-Kallio L, Aalto K, Peltola H: Serum C-reactive protein, erythrocyte sedimentation rate and white blood cell count in septic arthritis of children. Pediatr Infect Dis J 1997, 16:411-413.
• [24]Beltrán MA, Almonacid J, Vicencio A, Gutiérrez J, Cruces KS, Cumsille MA: Predictive value of white blood cell count and C-reactive protein in children with appendicitis. J Pediatr Surg 2007, 42:1208-1214.
• [25]Sorumen P, Kallio MJT, Kipli T, Peltola H: C-reactive protein is useful in distinguishing Gram stain-negative bacterial meningitis from viral meningitis in children. J Pediatr 1999, 134:725-729.
• [26]Sutinen J, Sombrero L, Paladin FJE, Julkunen I, Leinikki P, Hernandez E, Saniel M, Brato D, Ruutu P: Etiology of central nervous system infections in the Philippines and the role of serum C-reactive protein in excluding acute bacterial meningitis. Int J Infect Dis 1999, 3:88-93.
• [27]Chan DKL, Ho LY: Usefulness of C-reactive protein in the diagnosis of neonatal sepsis. Singapore Med J 1997, 38:252-255.
• [28]Benitz WE, Han MY, Madan A, Ramachandra P: Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics 1998, 102:e41.
• [29]Ng PC, Cheng SH, Chui KM, Fok TF, Wong MY, Wong W, Wong RPO, Cheung KL: Diagnosis of late onset neonatal sepsis with the cytokines, adhesion molecule, and C-reactive protein in preterm very low birth weight infants. Arch Dis Child 1997, 77:F221-F227.
• [30]Ehl S, Gering B, Bartmann P, Högel J, Pohlandt F: C-reactive protein is a useful marker for guiding duration of antibiotic therapy in suspected neonatal bacterial infection. Pediatrics 1997, 99:216-221.
• [31]Couto RC, Barbosa JAA, Pedrosa TMG, Biscione FM: C-reactive protein-guided approach may shorten length of antimicrobial treatment of culture-proven late-onset sepsis. An intervention study. Braz J Infect Dis 2007, 11(2):240-245.
• [32]Axt-Adam P, Van Der Wouden JC, Van Der Does E: Influencing behavior of physicians ordering laboratory tests: a literature study. Med Care 1993, 31:784-794.